An AU-rich element (ARE) in the 3-untranslated region (UTR) of bcl-2 mRNA has previously been shown to be responsible for destabilizing bcl-2 mRNA during apoptosis through increasing AUF1 binding. In the present study, we investigated the effect of the region upstream of the ARE on bcl-2 mRNA stability using serial deletion constructs of the 3-UTR of bcl-2. Deletion of 30 nucleotides mostly consisting of the CA repeats, located upstream of the ARE, resulted in the stabilization of bcl-2 mRNA abundance, in the absence or presence of the ARE. The specificity of the CA repeats in terms of destabilizing bcl-2 mRNA was proven by the substituting the CA repeats with other alternative repeats of purine/ pyriminine, but this had no effect on the stability of bcl-2 mRNA. CA repeats alone, however, failed to confer instability to bcl-2 or gfp reporter mRNAs, indicating a requirement for additional sequences in the upstream region of the 3-UTR. Serial deletion and replacement of a part of the region upstream of the CA repeats revealed that the entire 131-nucleotide upstream region is an essential prerequisite for the CA repeat-dependent destabilization of bcl-2 mRNA. Unlike the ARE, CA repeatmediated degradation of bcl-2 mRNA was not accelerated upon apoptotic stimulus. Moreover, the upstream sequences and CA repeats are conserved among mammals. Collectively, CA repeats contribute to the constitutive decay of bcl-2 mRNA in the steady states, thereby maintaining appropriate bcl-2 levels in mammalian cells.Apoptosis is a tightly controlled cellular suicide program that is critical for the successful development of multicellular organisms, the maintenance of normal tissue homeostasis, and removal of damaged cells (1). The protooncogene bcl-2, originally isolated from the chromosomal breakpoint of a t(14, 18)-bearing B cell lymphoma, serves as an important repressor of apoptosis in a variety of cell types (2, 3). In line with its significant role in altering susceptibility to apoptosis, investigations of the mechanisms by which bcl-2 expression is modulated may prove crucial for identifying therapeutic strategies for cancer and some neurodegenerative diseases and for defining the role of bcl-2 in the development of multiple tissues (4).Recent studies have indicated that bcl-2 is regulated at both the transcriptional and posttranscriptional levels. A number of negative transcriptional regulatory sites have been described in the bcl-2 promoter region (5, 6), and several transcription factors, including cAMP response element binding protein, AMyb and WT1, are known to be involved in the positive regulation of bcl-2 transcription (7-9). In addition to the promoter region, some sequences within the coding region, such as estrogen response elements, have also been demonstrated to mediate the transcriptional modulation of bcl-2, as was shown in breast cancer cell lines (10). The posttranscriptional modification of bcl-2 includes the phosphorylation of Bcl-2 at the putative mitogen-activated protein kinase sites, which confers resista...